Welcome : Guest

CONTRACT RESEARCH OUTSOURCING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Contract Research Outsourcing in US$ Million by the following Service Segments: Drug Discovery, Preclinical Research, and Clinical Research. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 115 companies including many key and niche players such as -

Albany Molecular Research, Inc.
Charles River Laboratories International, Inc.
Chiltern International Ltd.
ICON plc
INC Research, LLC

Click here to request a full list of companies covered in the report...

Code: MCP-1534
Price: $4500
Companies: 115
Pages: 282
Date: April 2017
Market Data Tables: 44
  Status: * New Report



TABLE OF CONTENTS


  CONTRACT RESEARCH OUTSOURCING (Complete Report) Pages : 282   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Outsourcing of R&D Projects to Propel CROs Services Market.....II-11$100
   Growth Drivers in a Nutshell.....II-2
Evolving Macro Trends Driving CRO Demand.....II-2
CROs to Significantly Drive Outsourcing Penetration.....II-2
1$100
   Focus on Efficient, Quality Services to Drive Specialty CROs Market.....II-31$100
   Rise in Investments to Boost Growth.....II-4
Key Therapeutic Areas of Clinical Trial Research.....II-4
1$100
   Table 1: Global Clinical Trial Services Market by Therapeutic Area: 2016 (includes corresponding Graph/Chart).....II-5
Primary Factors Influencing CRO Market.....II-5
Pharma and Biotech Companies to Increase Dependence on CROs.....II-5
1$350
   Outlook .....II-6
Notable Regional Developments.....II-6
1$100
   Future Model of CRO.....II-72$200
   CRO – A Highly Fragmented Market.....II-9 1$100
   Table 2: Leading Players in the Global Contract Research Outsourcing Market (2016E): Percentage Breakdown of Revenues by Player (includes corresponding Graph/Chart).....II-10

Table 3: Percentage Breakup of Life Sciences Revenues (2016) of Major Players by Service Type- Preclinical, Phase I, Phase IIA, Phase IIB, Phase III, Phase IV/ Post-Approval, Central Lab and Others.....II-10
1$350
   Large CROs Seek the Inorganic Growth Route.....II-11
Global CRO Marketspace – A Review of the M&A Activity in the Recent Years.....II-11
1$100
   Select M&A Activity in the Global CRO Market.....II-121$100
   Noteworthy Contracts of Major CROs.....II-13
CROs Adept with New Technologies to See More Business in Future.....II-13
1$100
   Streamlining Development of Novel Trial Designs.....II-141$100
   CROs with End-to End Capabilities in Demand.....II-15
Key Opportunities for CROs.....II-15
Technological Superiority – A Definite Advantage.....II-15
1$100
   Strategies and Tactical Programs for CROs.....II-16
Survival Strategies in Mature CRO Markets.....II-16
Exit from the Industry.....II-16
Expand Scale.....II-16
Capture Niche Segments.....II-16
Strategies to Tap Opportunities in Growing Markets.....II-16
Mobilize Funds.....II-16
Expand Other Services.....II-16
1$100
   Upgrade Technological and Knowledge Base.....II-17
Form Sub-Contracts or Regional Alliances.....II-17
1$100
   Increased Spend on R&D Outsourcing.....II-18
Table 4: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart).....II-18
1$350
   Table 5: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2016E (includes corresponding Graph/Chart).....II-19
Enhancing Site Selection and Patient Enrollment.....II-19
CROs Enter into Alliances to Improve Efficiencies.....II-19
1$350
   Adoption of Digital Technologies Gains Pace.....II-201$100
   Rising Late-Stage Services Demand and Budget Restraints Drive Market Growth.....II-21
Toxicology Services Gain Notable Attention.....II-21
1$100
   Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug
  Discovery – A Mutually Beneficial Strategy.....II-22
1$100
   Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration.....II-23
Table 6: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart).....II-23
1$350
   Table 7: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals (includes corresponding Graph/Chart).....II-241$350
   Focus on Regulatory Oversight and Enhanced Transparency Bodes Well for CROs.....II-25
eClinical Solutions Gain Traction.....II-25
1$100
   Other Noteworthy Market Trends.....II-26
CROs Monetize Data.....II-26
Service Differentiation – A Sustaining Strategy.....II-26
CROs Tie Up with Diagnostic Companies for Patients.....II-26
Research Networks Move to Cloud.....II-26
Application of Mobile Devices to Collect Real Time Data Gains Ground.....II-26
1$100
   CROs Provide Exclusive Offers to Lure Big Pharma.....II-27
Challenges Faced by Contract Research Organizations.....II-27
On-shore versus Offshore CRO Business.....II-27
Cutthroat Competition among CROs.....II-27
Management of Clinical Investigation.....II-27
Cost Containment.....II-27
1$100
   Safety Concerns on Clinical Trials.....II-28
Pipeline Blocks.....II-28
Surging Global Population Offers Increased Growth Opportunities.....II-28
1$100
   Table 8: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart).....II-291$350
   Aging Population Boosts Opportunities for CRO.....II-30 1$100
   Table 9: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart).....II-311$350
   Table 10: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart).....II-32
Increasing Healthcare Expenditure to Spur Demand for Generics.....II-32
2$350
   Table 11: Healthcare Spending as a Percentage of GDP by Region (2016E) (includes corresponding Graph/Chart).....II-341$350
   Concept.....II-35
Contract Research Organizations (CRO).....II-35
Contract Research Outsourcing.....II-35
Major CRO Services.....II-35
1$100
   Ancillary CRO Services.....II-36
Advantages from CRO.....II-36
Drug Discovery.....II-36
1$100
   Pre-Clinical Studies.....II-37
Clinical Research – Factors Encouraging CRO Services at Various Phases.....II-37
Phase I.....II-37
Phase II.....II-37
Phase III.....II-37
Phase IV.....II-37
1$100
   WuXi AppTec Takes Over HD Biosciences.....II-38
Laboratory Corporation of America Holdings to Acquire Pharmaceutical Product
  Development.....II-38
PRA Health Sciences and Takeda Pharmaceutical Inks New Partnership.....II-38
AMRI Enters into Alliance with Bruker Daltonics and HighRes Biosolutions.....II-38
Pharmaceutical Product Development Establishes Rare Disease and Pediatric Center of
  Excellence.....II-38
Pharmaceutical Product Development to Start Clinical Research Unit in Las
  Vegas.....II-38
1$100
   Bracket Acquires CLINapps.....II-39
PAREXEL International to Acquire ExecuPharm.....II-39
Cinven to Takeover BioClinica.....II-39
ICON to Takeover Clinical Research Management.....II-39
Pharmaceutical Product Development Acquires Evidera.....II-39
Velocity Fund Partners Acquires Indipharm.....II-39
Bioclinica Snaps Up Compass Research.....II-39
1$100
   Charles River Laboratories International Takes Over Agilux Laboratories.....II-40
Charles River Laboratories International Snaps Up Blue Stream Laboratories.....II-40
Charles River Laboratories International Acquires WIL Research.....II-40
Pharmaron Announces the Acquisition of Quotient Bioresearch.....II-40
Amulet Capital Partners Acquires SynteractHCR Holdings.....II-40
IMS Health Merges with Quintiles.....II-40
Almac Clinical Technologies Enters into Partnership with inVentiv Health.....II-40
1$100
   CSSi LifeSciences Unveils Fully Integrated Medical Device CRO.....II-41
Lovelace Biomedical Commences Operations as Preclinical CRO.....II-41
PAREXEL International Inks Services Agreement with Pfizer.....II-41
BioDuro Commences Operations as a Contract Research and Manufacturing Firm.....II-41
Charles River Laboratories International Forms Partnership with BioMotiv.....II-41
Laboratory Corporation of America Acquires Covance.....II-41
Charles River Laboratories International Snaps Up Oncotest.....II-41
Chiltern Acquires Theorem Clinical Research.....II-41
1$100
   Charles River Laboratories International Takes Over Celsis International.....II-42
Albany Molecular Research Unveils Integrated Drug Discovery Center.....II-42
1$100
   Albany Molecular Research, Inc. (USA).....II-43
Charles River Laboratories International, Inc. (USA).....II-43
Chiltern International Ltd. (UK).....II-43
1$100
   ICON plc (Ireland).....II-44
INC Research, LLC (USA).....II-44
InVentiv Health, Inc. (USA).....II-44
1$100
   Jubilant Biosys Ltd. (India).....II-45
Laboratory Corporation of America® Holdings (USA).....II-45
1$100
   PAREXEL International Corp. (USA).....II-46
Pharmaceutical Product Development, LLC. (USA).....II-46
Pharmaron (China).....II-46
PRA Health Sciences, Inc. (USA).....II-46
1$100
   Quintiles IMS Holdings, Inc. (USA).....II-47
Ricerca Biosciences LLC (USA).....II-47
Sygnature Discovery Limited (UK).....II-47
1$100
   SynteractHCR (USA).....II-48
WuXi AppTec (China).....II-48
1$100
   Table 12: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-491$350
   Table 13: World Historic Review for Contract Research Outsourcing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-501$350
   Table 14: World 14-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-511$350
   Table 15: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-521$350
   Table 16: World Historic Review for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-531$350
   Table 17: World 14-Year Perspective for Contract Research Outsourcing for Drug Discovery by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-541$350
   Table 18: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Preclinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-551$350
   Table 19: World Historic Review for Contract Research Outsourcing for Preclinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-561$350
   Table 20: World 14-Year Perspective for Contract Research Outsourcing for Preclinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-571$350
   Table 21: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-581$350
   Table 22: World Historic Review for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-591$350
   Table 23: World 14-Year Perspective for Contract Research Outsourcing for Clinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-601$350
   A. Market Analysis.....III-1
Outlook.....III-1
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings.....III-1
1$75
   Trial Services Witness Higher Demand.....III-2
Strong Demand for Data Management Services.....III-2
Focus on Innovation and Productivity.....III-2
1$75
   CROs Focus on Adaptive Clinical Trials.....III-3
Risk-based Monitoring Catches Pace.....III-3
Strategic Corporate Developments.....III-3
4$300
   Key Players.....III-74$300
   B. Market Analytics.....III-11
Table 24: US Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-11
1$200
   Table 25: US Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-121$200
   Table 26: US 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-131$200
   Market Analysis.....III-14
Table 27: Canadian Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-14
1$200
   Table 28: Canadian Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-151$200
   Table 29: Canadian 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Strategic Corporate Development.....III-17
1$75
   B. Market Analytics.....III-18
Table 30: Japanese Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-18
1$200
   Table 31: Japanese Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-191$200
   Table 32: Japanese 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-201$200
   A. Market Analysis.....III-21
Outlook.....III-21
Providers Expand Services in Downstream Drug Development.....III-21
Strategic corporate developments.....III-21
1$75
   Key Players.....III-222$150
   B. Market Analytics.....III-24
Table 33: European Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-24
1$200
   Table 34: European Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-251$200
   Table 35: European 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-261$200
   A. Market Analysis.....III-27
Outlook.....III-27
Asia-Pacific to Push up Volume Share in CRO Market.....III-27
1$75
   R&D Outsourcing in Life Sciences on Rise.....III-281$75
   Focus on Select Regional Markets.....III-29
China.....III-29
Market with Strong Growth Potential.....III-29
India.....III-29
1$75
   Australia.....III-30
Popular Destination for Early Phase Clinical Trials.....III-30
1$75
   Cost Savings through Tax Incentives.....III-31
Supportive Regulatory Framework.....III-31
Government Focus on Reducing Cost and Time.....III-31
1$75
   Superior Clinical Trial Quality.....III-32
Strategic Corporate Development.....III-32
Key Players.....III-32
2$150
   B. Market Analytics.....III-34
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-34
1$200
   Table 37: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-351$200
   Table 38: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-361$200
   Table 39: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-371$200
   Table 40: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Table 41: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Outlook.....III-40
Providers with Specialized Research Techniques to Boost Latin American CRO
  Market.....III-40
1$75
   B. Market Analytics.....III-41
Table 42: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-41
1$200
   Table 43: Rest of World Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-421$200
   Table 44: Rest of World 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-431$200
  
Total Companies Profiled: 116 (including Divisions/Subsidiaries - 120)

Region/Country Players

The United States 48 Canada 5 Japan 1 Europe 27 France 2 Germany 6 The United Kingdom 3 Spain 1 Rest of Europe 15 Asia-Pacific (Excluding Japan) 35 Latin America 4
Click here to request a full table of contents and more details on this project.